#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicle centre lymphoma follicular grade I II – III refractory Desmoplastic small round cell tumour Kaposi's sarcoma Pulmonary tuberculosis Congenital myopathy Univentricular heart Juvenile chronic myelomonocytic leukaemia Chronic lymphocytic leukaemia Congenital aplastic anaemia Neuroendocrine tumour of the lung Human papilloma virus immunisation Splenic marginal zone lymphoma Fibrous dysplasia of bone Thyroid cancer metastatic Henoch-Schonlein purpura nephritis More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Life with Disease Sjogren’s syndrome Hereditary angioedema – Trials in Disease Mucopolysaccharidosis II – Treatment Ewing’s sarcoma metastatic – Diagnostics Lymphatic malformation – Basic Information Haemophilia A without inhibitors – Basic Information Progressive supranuclear palsy – Treatment Encephalitis autoimmune – Trials in Disease Haemophilia B without inhibitors – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anhydrous Cholestyramine Neob Alnuctamab Sar-443579 Ag13909 Sym025 Esmolol Hydrochloride Amantadine Hydrochloride L-Histidine Botaretigene Sparoparvovec SAR443820 Pentixather Livmoniplimab Tulmimetostat Acetylcholine Chloride Varnimcabtagene Autoleucel ZODASIRAN Ciclesonide Abc-15A-116 Spesolimab More therapies…

    Learn about Your Condition

    Metastases to biliary tract Acute hepatic failure Polyneuropathy Affective disorder Neuroblastoma Endometrial cancer Paraesthesia Menopausal symptoms Mucous membrane pemphigoid Ovarian granulosa cell tumour Aortic valve disease Neuropathy peripheral Arteriovenous graft thrombosis Somatic symptom disorder Hepatoblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the use of botulinum toxin type A – haemagglutinin complex to help close the abdomen in patients with an open abdomen.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Spain

  • A study to evaluate the safety and effectiveness of VTX2735 sodium in patients with recurrent pericarditis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VTX2735 SODIUM
    Belgium France Greece

  • A study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Spain

  • A study to evaluate the safety of brimonidine tartrate gel in preventing hand and foot syndrome in patients with colorectal or breast cancer treated with capecitabine

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Brimonidine Tartrate
    France

  • Comparison of amoxicillin, amoxicillin-clavulanate, and placebo for the treatment of middle ear infection in children

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Otitis media
    Investigated Drugs:
    • Clavulanic Acid
    • Amoxicillin
    Finland

  • A study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • GRNA1599
    France
Previous Page
1 … 737 738 739 740 741 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!